
MedWorld Advisors Supports Acquisition of Behavior Science Technology in Strategic Sale to CentralReach
CentralReach, the leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, announces the acquisition of Behavior Sciences Technology (BST), a research-backed treatment fidelity platform designed to collect, measure, and track treatment fidelity for Applied Behavior Analysis (ABA) therapy in a standardized way.

Key Strategic M&A Insights from This Year’s Top 30 Companies Report
In this month's column, we look into why the inorganic activities of MPO's 2024 Top 30 participants are particularly interesting.

Insights Into Top Orthopedic Company Dynamics
Shining an analytical spotlight on four key areas for the top orthopedic device companies.

Should you do it alone?
Selling your business is a significant decision. As a business owner, chances are this question is often on your mind simply because of the number of phone calls you receive on a regular basis from would-be buyers.

How are changes in healthcare delivery impacting you as a medical device manufacturer?
Changes present challenges and opportunities. Are you capitalizing on any of these opportunities?

The Secrets of Medtech Enterprise Valuation for Sellers
It is crucial for business owners to understand the intrinsic value of their companies and the “multiple math” used to negotiate a valuation during a sale.

MedWorld Advisors announces the formation of the MedTech Laser Group
DEAL ANNOUNCEMENT - MedWorld Advisors is pleased to announce the formation of the MedTech Laser Group via the acquisition of shares of A.R.C Laser GmbH and of G.N.S. neoLaser Ltd by Afinum 9, advised by Afinum Management GmbH.

ODT Forum 2024: Enabling Success - A Discussion of the New Technologies Transforming Orthopedics
Watch Dave Sheppard moderate Enabling Success: A Discussion of the New Technologies Transforming Orthopedics, a panel at ODT Forum 2024.

Knowing what you want out of a deal is a key to a successful exit
Every seller has a different need and every buyer has their own motives. Below, find a few examples showcasing such difference in transactions; giving you something to think about if you’re thinking of selling.

Private Equity as an Exit Opportunity for Medtech Firms
Many industry competitors/strategics are now owned by a PE firm.

Dave Sheppard Guest on Rapport International Podcast The Global Marketing Show #13: Launching Medical Devices Internationally
Learn about building global relationships, why understanding country specific regulatory compliance is important, and more.

Is Being an OEM Supplier Part of Your Strategy?
Looking for growth in the medical device space? Becoming an original equipment manufacturer (OEM) supplier can bring results with long lasting rewards.

Is It Worth Following Trends in Medtech?
Before deciding whether a trend is worth a second look, its relevancy must first be determined.

Can MedTech and GLP-1s Peacefully Co-Exist?
Thankfully, one is not mutually exclusive of the other. Read more in our April column in Medical Product Outsourcing Magazine.

Thinking of selling; the numbers are on your side!
If you have good numbers you’ll get the attention of the PE firms at an excellent valuation (if you’re in MedTech). Catch the attention of a strategic and your numbers may get even a bit better!

MedCognetics Secures Groundbreaking Patent for Inclusive, Unbiased Medical Imaging AI Technology in Mammography
Congratulations to the team at MedCognetics for their continued progress towards making the future of mammography more efficient, economical, and most importantly more precise to ensure better patient outcomes for potential breast cancer patients.

Industry Dynamics from AAOS 2024
A closer examination of some key orthopedic device industry battlegrounds.

What’s in an acronym?
We all assume if we’re in healthcare we all speak the same language and when it comes to using acronyms that we’re all on the same page with what they mean. Well, not always.

The Top 9 Takeaways from MD&M West 2024
There are many key themes for C-Suite executives to consider in light of this year’s show.

Key Impacts to Consider for 2024?
Elections and the healthcare hot potato; Increase in M&A due to the dry powder and strategic valuations; Robotics and enabling technologies continuing to gain adoption; AI / ML continues to evolve.
Contact us.
We love what we do as we partner with our clients to bring them success. There are often many approaches to achieve your goals and will help you be successful. The best thing about our services is that YOU decide what YOU want to engage us for.
Connect with us for further details.
contact@medworldadvisors.com
(805) 441-0962
153 Summer Street
Andover, MA 01810